Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

0
299

from The Epoch Times:

The French study included 30,202 patients.

People who received hydroxychloroquine were less likely to die than those who did not, according to a new study.

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did not receive the drug combination, French researchers reported on Nov. 1.

TRUTH LIVES on at https://sgtreport.tv/

“This study represents the largest single-center study evaluating HCQ-AZ in the treatment of COVID-19. Similarly, to other large observational studies, it concludes that HCQ would have saved lives,” Dr. Didier Raoult, with Aix-Marseille Universite in Marseille, and his co-authors wrote.

The paper was published in the journal New Microbes and New Infections. It was released as a preprint earlier this year, but withdrawn because authors said they have changed their “analytic strategies.”

Researchers examined records from 30,423 patients with COVID-19 who were treated at another institution in Marseille, IHU Méditerranée Infection. They included all adults who tested positive for COVID-19 and who were treated in the hospital as an inpatient or an outpatient between March 2, 2020, and Dec. 31, 2021.

The study set ended up with 30,202 patients because treatment information was not available for the 221 others.

Most of the patients received off-label prescriptions of hydroxychloroquine and azithromycin (AZ), a common antibiotic.

Of the set, 23,172 patients received the drug combination. The other 7,030 did not.

Among those who received the drugs, 191, or 0.8 percent, died. Among those who did not, 344, or 4.8 percent, passed away.

Read More @ TheEpochTimes.com